Cargando…
Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban
BACKGROUND: Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported. Case Pres...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334074/ https://www.ncbi.nlm.nih.gov/pubmed/35911864 http://dx.doi.org/10.1155/2022/8156942 |
_version_ | 1784759020178898944 |
---|---|
author | Farooqui, Azhar Lwin, Tin Costa, Daniel Hetherington, Simon Mattu, Raj |
author_facet | Farooqui, Azhar Lwin, Tin Costa, Daniel Hetherington, Simon Mattu, Raj |
author_sort | Farooqui, Azhar |
collection | PubMed |
description | BACKGROUND: Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported. Case Presentation. This case report describes left ventricular thrombus progression/recurrence in a patient anticoagulated with Apixaban undergoing implantable cardioverter defibrillator to cardiac resynchronisation therapy with defibrillator upgrade procedure. He was thereafter changed to warfarin. Contrast echocardiogram at 6 months follow-up did not identify the previously demonstrated mural thrombus. CONCLUSION: Prospective randomised control trials should be conducted in patients with left ventricular thrombus to compare anticoagulants, assess the efficacy and safety of DOACs, and evaluate uninterrupted DOAC versus transient withdrawal for cardiac device procedures. |
format | Online Article Text |
id | pubmed-9334074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-93340742022-07-29 Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban Farooqui, Azhar Lwin, Tin Costa, Daniel Hetherington, Simon Mattu, Raj Case Rep Cardiol Case Report BACKGROUND: Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported. Case Presentation. This case report describes left ventricular thrombus progression/recurrence in a patient anticoagulated with Apixaban undergoing implantable cardioverter defibrillator to cardiac resynchronisation therapy with defibrillator upgrade procedure. He was thereafter changed to warfarin. Contrast echocardiogram at 6 months follow-up did not identify the previously demonstrated mural thrombus. CONCLUSION: Prospective randomised control trials should be conducted in patients with left ventricular thrombus to compare anticoagulants, assess the efficacy and safety of DOACs, and evaluate uninterrupted DOAC versus transient withdrawal for cardiac device procedures. Hindawi 2022-07-21 /pmc/articles/PMC9334074/ /pubmed/35911864 http://dx.doi.org/10.1155/2022/8156942 Text en Copyright © 2022 Azhar Farooqui et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Farooqui, Azhar Lwin, Tin Costa, Daniel Hetherington, Simon Mattu, Raj Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title | Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title_full | Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title_fullStr | Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title_full_unstemmed | Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title_short | Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban |
title_sort | recurrence of lv thrombus in a patient with severe ischaemic cardiomyopathy anticoagulated with apixaban |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334074/ https://www.ncbi.nlm.nih.gov/pubmed/35911864 http://dx.doi.org/10.1155/2022/8156942 |
work_keys_str_mv | AT farooquiazhar recurrenceoflvthrombusinapatientwithsevereischaemiccardiomyopathyanticoagulatedwithapixaban AT lwintin recurrenceoflvthrombusinapatientwithsevereischaemiccardiomyopathyanticoagulatedwithapixaban AT costadaniel recurrenceoflvthrombusinapatientwithsevereischaemiccardiomyopathyanticoagulatedwithapixaban AT hetheringtonsimon recurrenceoflvthrombusinapatientwithsevereischaemiccardiomyopathyanticoagulatedwithapixaban AT matturaj recurrenceoflvthrombusinapatientwithsevereischaemiccardiomyopathyanticoagulatedwithapixaban |